VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
CRON
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
CRONCronos Group Inc.
$2.75$1.0B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders

CRON logoCronos Group Inc.(CRON)Earnings, Financials & Key Ratios

CRON•NASDAQ
$2.75
Price updated Jul 7, 2026
SectorHealthcareIndustrySpecialty & Generic PharmaSub-IndustryCannabis and cannabinoid product companies
AboutCronos Group Inc. operates as a cannabinoid company. It manufactures, markets, and distributes hemp-derived supplements and cosmetic products through e-commerce, retail, and hospitality partner channels under the Lord Jones and Happy Dance brands in the United States. The company is also involved in the cultivation, manufacture, and marketing of cannabis and cannabis-derived products for the medical and adult-use markets. It sells cannabis and cannabis products, including dried cannabis, pre-rolls, edibles, concentrates, and cannabis extracts through wholesale and direct-to-client channels under its wellness platform, PEACE NATURALS; and operates under adult-use brands, Spinach. It also exports dried cannabis and cannabis oils to Germany, Israel, and Australia. Cronos Group Inc. was founded in 2012 and is based in Toronto, Canada.Show more
  • Revenue$193M+64.4%
  • EBITDA-$810K+98.8%
  • Net Income-$9M-123.0%
  • EPS (Diluted)-0.02-122.3%
  • Gross Margin32.46%+51.5%
  • EBITDA Margin-0.42%+99.3%
  • Operating Margin-1.51%+97.7%
  • Net Margin-4.89%-114.0%
  • ROE-0.84%-122.5%

CRON Price & Volume

Cronos Group Inc. (CRON) stock price & volume — 10-year historical chart

Loading chart...

Cash Reserves Buffer Volatile Operational Margin Performance

Investment Thesis • Updated 2026Q1

VerdictNeutral
Growth:Accelerating
Profitability:Strained
Financial:Fortress
Cash Flow:Improving
Primary Risk:Regulatory and geopolitical volatility

Key Thesis Takeaways

  • Cronos Group maintains a fortress balance sheet with $824.6 million in cash, providing significant strategic optionality despite inconsistent operational profitability.
  • While recent revenue growth of 38.2% in 2026Q1 suggests successful market penetration, the firm struggles to scale operating leverage, evidenced by a negative 3.2% operating margin.
  • Investors should monitor the sustainability of this growth and the potential for future goodwill impairment, given that goodwill has risen to $65.7 million from $1.0 million in 2024Q2.

Verdict Logic

while the $824.6 million cash position provides a substantial safety net, the firm's inability to maintain consistent positive operating margins, which stood at -3.2% in 2026Q1, suggests that core operational sustainability remains unproven.

CRON Growth Metrics

Cronos Group Inc. (CRON) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years49.77%
5 Years32.85%
3 Years30.63%
TTM65.09%

Profit CAGR

10 Years-
5 Years-
3 Years-
TTM-104.06%

EPS CAGR

10 Years-
5 Years-
3 Years-
TTM-101.77%

Return on Capital

10 Years-10.82%
5 Years-8.55%
3 Years-4.91%
Last Year-0.26%

CRON Recent Earnings

Cronos Group Inc. (CRON) EPS & revenue vs analyst estimates — last 4 quarters

Full history →
●Beat EPS 2/12 qtrs (17%)●Beat Revenue 4/12 qtrs (33%)
Q2 2026Latest
May 11, 2026
Metric
Actual
Est
EPS
$0.01+0.0%
$0.01
Rev
$45M+7.1%
$42M
Q1 2026
Feb 26, 2026
Metric
Actual
Est
EPS
$0.00-147.0%
$0.01
Rev
$45M+15.0%
$39M
Q4 2025
Nov 6, 2025
Metric
Actual
Est
EPS
$0.07+250.0%
$0.02
Rev
$36M-5.5%
$38M
Q3 2025
Aug 7, 2025
Metric
Actual
Est
EPS
$0.10-400.0%
$0.02
Rev
$32M-13.3%
$37M
QuarterDateEPS (Act vs Est)Revenue (Act vs Est)
Q2 2026LatestMay 11, 2026
$0.01vs $0.01+0.0%
$45Mvs $42M+7.1%
Q1 2026Feb 26, 2026
$0.00vs $0.01-147.0%
$45Mvs $39M+15.0%
Q4 2025Nov 6, 2025
$0.07vs $0.02+250.0%
$36Mvs $38M-5.5%
Q3 2025Aug 7, 2025
$0.10vs $0.02-400.0%
$32Mvs $37M-13.3%
Based on last 12 quarters of dataView full earnings history →

Latest CRON News

Recent stock market news and headlines for Cronos Group Inc. (CRON)

MarijuanaStocks·1 day ago
Top Canadian Marijuana Stock Picks For Investors Today

As the cannabis sector continues to grow, it has marijuana stock investors seeing green. There has been a long, volatile battle for most of the time cannabis companies have been publicly traded. Even during the moments when many used pot stocks to get quick profits, given how the sector once began. At one point, a great deal of hype and speculation fueled investors in taking up positions for particular cannabis stocks.

GlobeNewsWire·Jun 30, 2026
Cronos Announces Appointment of ATB Cormark as its Broker for Share Repurchases in Canada

TORONTO, June 30, 2026 (GLOBE NEWSWIRE) -- Cronos Group Inc. (“Cronos” or the “Company”) (NASDAQ: CRON) (TSX: CRON), an innovative global cannabis company, announced today that it has appointed ATB Capital Markets Corp. (“ATB Cormark”) to act as its broker in connection with share repurchases over the facilities of the TSX or other alternative Canadian trading systems, in place of Virtu Canada Corp., under its previously announced share repurchase program.

Zacks Investment Research·Jun 24, 2026
CRON Strengthens Global Footprint: Is the Cannabis Stock Worth Buying?

Cronos Group posts 40% Q1 revenue growth, gains share in Canada and expands abroad, but fierce cannabis competition keeps investors cautious.

GlobeNewsWire·Jun 22, 2026
Cronos Group Inc. Announces Results of 2026 Annual Meeting of Shareholders

TORONTO, June 22, 2026 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) today announced that at its Annual Meeting of Shareholders held on Thursday, June 18, 2026 (the “Meeting”), shareholders holding a total of 271,828,759 common shares of the Company voted in person or by proxy, representing 72.24% of the total number of common shares of the Company outstanding.

Globe News Wire·Jun 22, 2026
Cronos Group Inc. Announces Results of 2026 Annual Meeting of Shareholders

TORONTO, June 22, 2026 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) ("Cronos" or the "Company") today announced that at its Annual Meeting of Shareholders held on Thursday, June 18, 2026 (the "Meeting"), shareholders holding a total of 271,828,759 common shares of the Company voted in person or by proxy, representing 72.

Peers Comparison

Key metrics vs top competitors for Cronos Group Inc. (CRON)

Full Screener →
CompanyPriceMarket CapP/E RatioRev Growth (1Y)Net MarginROEDiv Yield
CRON logoCRONCronos Group Inc.Current
$2.75$1.03B-112.2464.4%-4.89%-0.84%—
CGC logoCGCCanopy Growth Corporation
$0.95$365.74M-1.535.8%-91.63%-38.64%—
TLRY logoTLRYTilray Brands, Inc.
$4.31$502.21M-0.134.84%-252.55%-136.55%—
ACB logoACBAurora Cannabis Inc.
$2.67$165.39M-1.77-6.37%-24.14%-13.4%—
IIPR logoIIPRInnovative Industrial Properties, Inc.
$61.81$1.77B15.73-13.8%45.58%6.41%—
SMG logoSMGThe Scotts Miracle-Gro Company
$66.79$3.89B27.04-3.93%3.27%——

Compare CRON vs Peers

Cronos Group Inc. (CRON) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs CGC

Most directly comparable listed peer for CRON.

Scale Benchmark

vs PM

Larger-name benchmark to compare CRON against a more recognizable public peer.

Peer Set

Compare Top 5

vs CGC, TLRY, ACB, IIPR

CRON SEC Filings & Documents

Cronos Group Inc. (CRON) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

6
Material company update

May 11, 2026·SEC

Material company update

Feb 26, 2026·SEC

Material company update

Dec 9, 2025·SEC

10-K Annual Reports

4
FY 2026

Feb 26, 2026·SEC

FY 2025

Feb 27, 2025·SEC

FY 2024

Feb 29, 2024·SEC

10-Q Quarterly Reports

6
FY 2026

May 11, 2026·SEC

FY 2025

Nov 6, 2025·SEC

FY 2025

Aug 7, 2025·SEC

Get notified when CRON posts new earnings or crosses analyst targets

Free. No account needed. Unsubscribe any time.

Free. Unsubscribe any time.

CRON Frequently Asked Questions

Cronos Group Inc. (CRON) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials
What is Cronos Group Inc.'s revenue?

Cronos Group Inc. (CRON) reported $205.7M in revenue for fiscal year 2025.

How fast is Cronos Group Inc. growing?

Cronos Group Inc. (CRON) grew revenue by 64.4% over the past year. This is strong growth.

Is CRON profitable?

Cronos Group Inc. (CRON) reported a net loss of $2.0M for fiscal year 2025.

Dividend & Returns
What is CRON's return on equity?

Cronos Group Inc. (CRON) has a return on equity (ROE) of -0.8%. Negative ROE indicates the company is unprofitable.

What is Cronos Group Inc.'s free cash flow?

Cronos Group Inc. (CRON) generated $26.5M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.

What if you invested $1,000 in CRON back in 2013?

Total return calculator · dividends reinvested · 13+ years of data

See returns →